keyword
Keywords intensity-modulated radiation ...

intensity-modulated radiation therapy

https://read.qxmd.com/read/38634572/gbm-immunotherapy-macrophage-impacts
#1
REVIEW
Nina Loginova, Denis Aniskin, Peter Timashev, Ilya Ulasov, Rajesh Kumar Kharwar
BACKGROUND: Glioblastoma (GBM) is an extremely aggressive form of brain tumor with low survival rates. Current treatments such as chemotherapy, radiation, and surgery are problematic due to tumor growth, invasion, and tumor microenvironment. GBM cells are resistant to these standard treatments, and the heterogeneity of the tumor makes it difficult to find a universal approach. Progression of GBM and acquisition of resistance to therapy are due to the complex interplay between tumor cells and the TME...
April 18, 2024: Immunological Investigations
https://read.qxmd.com/read/38633140/long-term-control-with-proton-beam-therapy-for-recurrent-prostate-cancer-in-the-right-perineum-following-intensity-modulated-radiation-therapy-a-case-report
#2
Yojiro Ishikawa, Motohisa Suzuki, Ichiro Seto, Yoshiaki Takagawa, Masao Murakami
Radiation therapy (RT) is commonly used for the treatment of prostate cancer, with intensity-modulated radiation therapy (IMRT) and proton beam therapy (PBT) being the utilized modalities. This case report outlines the treatment course of a recurrent prostate cancer lesion in the right perineal musculature managed with proton therapy following IMRT. A 64-year-old Japanese man, diagnosed with prostate cancer and categorized as high risk according to the National Comprehensive Cancer Network guidelines, underwent six months of androgen deprivation therapy, which included bicalutamide and degarelix acetate...
April 2024: Curēus
https://read.qxmd.com/read/38631538/incorporating-functional-lung-imaging-fli-into-radiation-therapy-planning-in-patients-with-lung-cancer-a-systematic-review-and-meta-analysis
#3
REVIEW
Julie Midroni, Rohan Salunkhe, Zhihui Liu, Ronald Chow, Gabriel Boldt, David Palma, Douglas Hoover, Yevgeniy Vinogradskiy, Srinivas Raman
PURPOSE: To provide an understanding of current FLI techniques, and their potential to improve dosimetry and outcomes for lung cancer patients receiving radiation therapy (RT). METHODS: EMBASE, PubMed, and Cochrane Library were searched from 1990 until April 2023. Articles were included if they reported on FLI in one of: techniques, incorporation into RT planning for lung cancer, quantification of RT-related outcomes for lung cancer patients. Studies involving all RT modalities, including stereotactic body radiotherapy and particle therapy, were included...
April 15, 2024: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/38628522/primary-extranodal-marginal-zone-mucosa-associated-lymphoid-tissue-type-b-cell-lymphoma-involving-the-dura-a-case-report
#4
Ryo Hamamoto, Toshinari Kawasaki, Masashi Oda, Sosuke Sumiyoshi, Kosuke Hayashi, Tamaki Kobayashi, Yoshihiko Ioroi, Tatsuki Uchiyama, Motohiro Takayama, Masaaki Saiki
BACKGROUND: Primary extranodal marginal zone mucosa-associated lymphoid tissue-type B-cell lymphoma (EMZMBCL), which presents as a dural mass, is a rare intracranial tumor that mimics a subdural hematoma or meningioma. CASE DESCRIPTION: A 49-year-old woman presented to our hospital with transient right upper limb paresis, dysarthria for 10 min, and ongoing right upper-limb numbness. Computed tomography (CT) of the head revealed extra-axial lesions in the left frontal and parietal lobes...
2024: Surgical Neurology International
https://read.qxmd.com/read/38627747/current-practices-of-craniospinal-irradiation-techniques-in-turkey-a-comprehensive-dosimetric-analysis
#5
JOURNAL ARTICLE
Öznur Şenkesen, Evrim Tezcanlı, Fadime Alkaya, Burçin İspir, Serap Çatlı, Abdullah Yeşil, Ebrar Bezirganoglu, Sezgi Turan, Canan Köksal, Gülay Güray, Emel Hacıislamoğlu, İsmail Faruk Durmuş, Şeyma Çavdar, Telat Aksu, Nurten Çolak, Esra Küçükmorkoç, Mustafa Doğan, Tülay Ercan, Fatih Karaköse, Vildan Alpan, Cemile Ceylan, Gökhan Poyraz, Nilgül Nalbant, Şeyda Kınay, Servet İpek, Namık Kayalılar, Hamza Tatlı, Mingyao Zhu
OBJECTIVE: This study evaluates various craniospinal irradiation (CSI) techniques used in Turkish centers to understand their advantages, disadvantages and overall effectiveness, with a focus on enhancing dose distribution. METHODS: Anonymized CT scans of adult and pediatric patients, alongside target volumes and organ-at-risk (OAR) structures, were shared with 25 local radiotherapy centers. They were tasked to develop optimal treatment plans delivering 36 Gy in 20 fractions with 95% PTV coverage, while minimizing OAR exposure...
April 16, 2024: Radiation Oncology
https://read.qxmd.com/read/38617757/clinical-radiomics-nomogram-for-the-risk-prediction-of-esophageal-fistula-in-patients-with-esophageal-squamous-cell-carcinoma-treated-with-intensity-modulated-radiation-therapy-or-volumetric-modulated-arc-therapy
#6
JOURNAL ARTICLE
Zhaohui Li, Jie Gong, Liu Shi, Jie Li, Zhi Yang, Guangjin Chai, Bo Lv, Geng Xiang, Bin Wang, Shamus R Carr, Alfonso Fiorelli, Mei Shi, Yilin Zhao, Lina Zhao
BACKGROUND: Esophageal fistula (EF) is a serious adverse event as a result of radiotherapy in patients with esophageal cancer (EC). We aimed to identify the predictive factors and establish a prediction model of EF in patients with esophageal squamous cell carcinoma (ESCC) who underwent intensity-modulated radiation therapy (IMRT) or volumetric-modulated arc therapy (VMAT). METHODS: Patients with ESCC treated with IMRT or VMAT from January 2013 to December 2020 at Xijing Hospital were retrospectively analyzed...
March 29, 2024: Journal of Thoracic Disease
https://read.qxmd.com/read/38614283/postoperative-radiotherapy-results-in-192-epithelial-thymic-tumours-patients-with-10%C3%A2-years-of-follow-up
#7
JOURNAL ARTICLE
Hugo Lopez, Angela Botticella, Farid Belkhir, Benjamin Besse, Elie Fadel, Olaf Mercier, Antonin Levy, Cécile Le Péchoux
PURPOSE: To assess the prognostic factors and patterns of failure of patients consecutively treated with surgery and postoperative radiation therapy (PORT) for thymic epithelial tumours (TET). PATIENTS AND METHODS: Data from 192 TET patients who were operated and received PORT at a single centre from 1990 to 2019 was retrospectively analysed. RESULTS: Most patients had thymoma (77 %, B247%), were classified Masaoka-Koga stage III (35 %) or IV (32 %) and had a R0 (75 %) resection...
April 11, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/38610008/developing-an-educational-hub-impact-of-a-distance-learning-curriculum-in-a-multinational-cohort
#8
JOURNAL ARTICLE
Meridith L Balbach, Grantly Neely, Afua Yorke, Evangelina Figueroa-Medina, Jonathan Paly, Rebecca M Shulman, Claire Dempsey, Adam Shulman, Cesar Della Biancia, William B Cutrer, Benjamin C Li
PURPOSE: To address a gap in radiation oncology education in low- and middle-income countries (LMICs), we sought to evaluate the effectiveness and generalizability of a refined curriculum on intensity modulated radiotherapy (IMRT) offered to existing radiation therapy (RT) clinics across Africa and Latin America (LATAM) at no cost. METHODS: A curriculum was created based on prior needs assessments and adapted for participating medical physicists, radiation oncologists, radiation therapists, and trainees in LMICs...
April 12, 2024: BMC Medical Education
https://read.qxmd.com/read/38608932/recommendations-for-post-operative-radiotherapy-after-complete-resection-of-thymoma-a-french-delphi-consensus-initiative
#9
JOURNAL ARTICLE
Clémence Basse, Jonathan Khalifa, François Thillays, Cécile Le Pechoux, Jean-Michel Maury, Pierre-Emmanuel Bonte, Alexandre Coutte, Nicolas Pourel, Vincent Bourbonne, Olivier Pradier, Aurélie Belliere, Florence Le Tinier, Mélanie Deberne, Ronan Tanguy, Fabrice Denis, Laetitia Padovani, Audrey Zaccariotto, Thierry Molina, Lara Chalabreysse, Geoffrey Brioude, Bertrand Delatour, Jean-Christophe Faivre, Kim Cao, Philippe Giraud, François-Georges Riet, Sébastien Thureau, Delphine Antoni, Carole Massabeau, Audrey Keller, Emilie Bonnet, Delphine Lerouge, Etienne Martin, Nicolas Girard, Angela Botticella
BACKGROUND: Thymomas are rare intrathoracic malignancies that can relapse after surgery. Whether or not Post-Operative Radiotherapy (PORT) should be delivered after surgery remains a major issue. RADIORYTHMIC is an ongoing, multicenter, randomized phase 3 trial addressing this question in patients with completely R0 resected Masaoka-Koga stage IIb/III thymoma. Experts in the field met to develop recommendations for PORT. METHODS: A scientific committee from the RYTHMIC network identified key issues regarding the modalities of PORT in completely resected thymoma...
April 10, 2024: Journal of Thoracic Oncology
https://read.qxmd.com/read/38607778/observations-of-the-effectiveness-dosage-and-prognosis-of-intensity-modulated-radiation-therapy-under-ultrasonic-guidance-for-cervical-cancer-patients
#10
JOURNAL ARTICLE
Chenxi Li, Jian Li, Yao Lu, Jiahui Hou, Zhaoyu Zhi, Baocun Zhao, Xiumei Zhang
BACKGROUND: Volumetric modulated arc therapy (VMAT) guided by ultrasound is a novel radiation therapy technique that facilitates the delineation of the tumor target area under image guidance, enhancing the precision of radiation therapy and maximizing the protection of surrounding tissues. OBJECTIVE: The objective of this paper is to investigate the effectiveness of VMAT under ultrasonic guidance for cervical cancer patients and its impact on radiotherapy dosage and prognosis...
February 29, 2024: Technology and Health Care: Official Journal of the European Society for Engineering and Medicine
https://read.qxmd.com/read/38602670/american-radium-society-appropriate-use-criteria-for-unresectable-locally-advanced-non-small-cell-lung-cancer
#11
JOURNAL ARTICLE
George Rodrigues, Kristin A Higgins, Andreas Rimner, Arya Amini, Joe Y Chang, Stephen G Chun, Jessica Donington, Martin J Edelman, Matthew A Gubens, Puneeth Iyengar, Benjamin Movsas, Matthew S Ning, Henry S Park, Andrea Wolf, Charles B Simone
IMPORTANCE: The treatment of locally advanced non-small cell lung cancer (LA-NSCLC) has been informed by more than 5 decades of clinical trials and other relevant literature. However, controversies remain regarding the application of various radiation and systemic therapies in commonly encountered clinical scenarios. OBJECTIVE: To develop case-referenced consensus and evidence-based guidelines to inform clinical practice in unresectable LA-NSCLC. EVIDENCE REVIEW: The American Radium Society (ARS) Appropriate Use Criteria (AUC) Thoracic Committee guideline is an evidence-based consensus document assessing various clinical scenarios associated with LA-NSCLC...
April 11, 2024: JAMA Oncology
https://read.qxmd.com/read/38600819/reirradiation-of-metastases-of-the-central-nervous-system-part-2-metastatic-epidural-spinal-cord-compression
#12
JOURNAL ARTICLE
Dirk Rades, Charles B Simone, Henry C Y Wong, Edward Chow, Shing Fung Lee, Peter A S Johnstone
An increasing number of patients irradiated for metastatic epidural spinal cord compression (MESCC) experience an in-field recurrence and require a second course of radiotherapy. Reirradiation can be performed with conventional radiotherapy or highly-conformal techniques such as intensity-modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT), and stereotactic body radiation therapy (SBRT). When using conventional radiotherapy, a cumulative biologically effective dose (BED) ≤120 calculated with an α/β value of 2 Gy (Gy2) was not associated with radiation myelopathy in a retrospective study of 124 patients and is considered safe...
March 21, 2024: Annals of Palliative Medicine
https://read.qxmd.com/read/38592098/understanding-and-managing-pineal-parenchymal-tumors-of-intermediate-differentiation-an-in-depth-exploration-from-pathology-to-adjuvant-therapies
#13
REVIEW
Andrea Bianconi, Flavio Panico, Bruna Lo Zito, Andrea Do Trinh, Paola Cassoni, Umberto Ricardi, Diego Garbossa, Fabio Cofano, Cristina Mantovani, Luca Bertero
BACKGROUND: Pineal parenchymal cell tumors constitute a rare group of primary central nervous system neoplasms (less than 1%). Their classification, especially the intermediate subtype (PPTIDs), remains challenging. METHODS: A literature review was conducted, navigating through anatomo-pathological, radiotherapy, and neurosurgical dimensions, aiming for a holistic understanding of these tumors. RESULTS: PPTIDs, occupying an intermediate spectrum of malignancy, reveal diverse histological patterns, mitotic activity, and distinct methylation profiles...
February 23, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38591178/survival-outcomes-and-toxicity-profiles-among-patients-with-nonmetastatic-nasopharyngeal-carcinoma-treated-with-intensity-modulated-radiotherapy-imrt-versus-imrt-carbon-ion-radiotherapy-a-propensity-score-matched-analysis
#14
JOURNAL ARTICLE
Yujiao Li, Xiyin Guan, Xing Xing, Chaosu Hu
OBJECTIVES: To compare survival outcomes and toxic effects among patients with newly diagnosed nonmetastatic nasopharyngeal carcinoma (NPC) when treated with intensity-modulated radiotherapy (IMRT) versus IMRT + carbon-ion radiotherapy (CIRT). METHODS: We performed a retrospective propensity score matching analysis (1:1) of patients treated with IMRT and IMRT + CIRT. Descriptive statistics were used to examine the baseline characteristics of the patients...
April 9, 2024: Head & Neck
https://read.qxmd.com/read/38585011/long-term-survival-toxicities-and-the-role-of-chrono-chemotherapy-with-different-infusion-rates-in-locally-advanced-nasopharyngeal-carcinoma-patients-treated-with-intensity-modulated-radiation-therapy-a-retrospective-study-with-a-5-year-follow-up
#15
JOURNAL ARTICLE
Lina Liu, Xunyan Luo, Weili Wu, Yuanyuan Li, Jinhua Long, Xiuling Luo, Xiaoxiao Chen, Xiuyun Gong, Chaofen Zhao, Qianyong He, Zhuoling Li, Kai Shang, Yue Chen, Xu Xinyu, Feng Jin
PURPOSE: This study aimed to evaluate 5-year outcomes and the late toxicity profile of chrono-chemotherapy with different infusion rates in patients with locally advanced nasopharyngeal carcinoma (NPC). METHODS AND MATERIALS: Our retrospective analysis included 70 patients with locally advanced NPC stages III and IVB (according to the 2010 American Joint Committee on Cancer staging system). Patients were treated with two cycles of induction chemotherapy (IC) before concurrent chemoradiotherapy (CCRT) at Guizhou Cancer Hospital...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38576855/stereotactic-body-radiation-therapy-in-patients-with-centrally-located-hepatocellular-carcinoma-a-retrospective-single-arm-multi-center-study
#16
JOURNAL ARTICLE
Dan-Xue Zheng, Yi-Xing Chen, Jing Sun, Yong Hu, Ping Yang, Yang Zhang, Xue-Zhang Duan, Zhao-Chong Zeng
Centrally located hepatocellular carcinoma (HCC) is difficult to be radically resected due to its special location close to major hepatic vessels. Thus, we aimed to assess whether stereotactic body radiation therapy (SBRT) can be an effective and safe approach for centrally located HCC. This retrospective study included 172 patients with centrally located HCC who were treated with SBRT. Overall survival (OS) was analyzed as the primary endpoint. Rates of progression-free survival (PFS), local control, intrahepatic relapse, extrahepatic metastasis and toxicities were analyzed as secondary endpoints...
May 2024: Clinical and Translational Radiation Oncology
https://read.qxmd.com/read/38576174/dosimetric-validation-of-intensity-modulated-bolus-electron-conformal-therapy-planning-and-delivery-using-an-anthropomorphic-cylindrical-head-phantom
#17
JOURNAL ARTICLE
Andrew S McGuffey, Garrett M Pitcher, Kevin J Erhart, Kenneth R Hogstrom
PURPOSE: This work investigated the dosimetric accuracy of the intensity-modulated bolus electron conformal therapy (IM-BECT) planning and delivery process using the decimal ElectronRT (eRT) treatment planning system. METHODS: An IM-BECT treatment plan was designed using eRT for a cylindrical, anthropomorphic retromolar trigone phantom. Treatment planning involved specification of beam parameters and design of a variable thickness wax bolus and Passive Radiotherapy Intensity Modulator for Electrons (PRIME) device, which was comprised of 33 tungsten island blocks of discrete diameters from 0...
April 4, 2024: Journal of Applied Clinical Medical Physics
https://read.qxmd.com/read/38575432/reducing-salivary-toxicity-with-adaptive-radiotherapy-restart-a-randomized-controlled-trial-comparing-conventional-imrt-to-adaptive-imrt-in-head-and-neck-squamous-cell-carcinomas
#18
JOURNAL ARTICLE
S Ghosh Laskar, S Sinha, A Kumar, A Samanta, S Mohanty, S Kale, F Khan, S Lewis Salins, V Murthy
BACKGROUND: The utility of Adaptive Radiotherapy (ART) in Head and Neck Squamous Cell Carcinoma (HNSCC) remains to be ascertained. While multiple retrospective and single-arm prospective studies have demonstrated its efficacy in decreasing parotid doses and reducing xerostomia, adequate randomized evidence is lacking. METHODS AND ANALYSIS: ReSTART (Reducing Salivary Toxicity with Adaptive Radiotherapy) is an ongoing phase III randomized trial of patients with previously untreated, locally advanced HNSCC of the oropharynx, larynx, and hypopharynx...
March 18, 2024: Clinical Oncology: a Journal of the Royal College of Radiologists
https://read.qxmd.com/read/38574312/phase-ii-trial-of-cisplatin-gemcitabine-and-intensity-modulated-radiation-therapy-for-locally-advanced-vulvar-squamous-cell-carcinoma-nrg-oncology-gog-study-279
#19
JOURNAL ARTICLE
Neil S Horowitz, Wei Deng, Ivy Peterson, Robert S Mannel, Spencer Thompson, Elizabeth Lokich, Tashanna Myers, Parvis Hanjani, David M O'Malley, Ki Young Chung, David S Miller, Frederick R Ueland, Don S Dizon, Austin Miller, Jyoti S Mayadev, Charles A Leath, Bradley J Monk
PURPOSE: To assess efficacy and toxicity of cisplatin (C) and gemcitabine (G) with intensity-modulated radiation therapy (IMRT) in patients with locally advanced vulvar cancer not amenable to surgery. METHODS: Patients enrolled in a single-arm phase II study. Pretreatment inguinal-femoral nodal assessment was performed. Sixty-four Gy IMRT was prescribed to the vulva, with 50-64 Gy delivered to the groins/low pelvis. Radiation therapy (RT) plans were quality-reviewed pretreatment...
April 4, 2024: Journal of Clinical Oncology
https://read.qxmd.com/read/38573515/does-lower-dose-pilocarpine-have-a-role-in-radiation-induced-xerostomia-in-the-modern-radiotherapy-era-a-single-center-experience-based-on-patient-reported-outcome-measures
#20
JOURNAL ARTICLE
Dilek Gül, Beste M Atasoy, Ece Ercan, Zilan Başkan, Kıvanç Bektaş Kayhan
PURPOSE: This study aims to investigate the efficacy of lower dose pilocarpine in alleviating late dry mouth symptoms in head and neck cancer patients received radiotherapy. METHODS: Eighteen head and neck cancer patients experiencing persistent dry mouth were enrolled in this study. All participants started pilocarpine treatment a median of 6 months post-radiotherapy. Initially, patients received pilocarpine at 5 mg/day, with a gradual increase to the recommended dose of 15 mg/day...
April 4, 2024: European Archives of Oto-rhino-laryngology
keyword
keyword
158730
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.